Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas
Clinical trial NCT00795457 · COMPLETED
Trial details
- NCT number
- NCT00795457
- Sponsor
- Ian F. Pollack, M.D.
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2013-02-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.